How do Hallucinogens Affect your Brain?
Every week, the Wonder Newsroom asks our community to pose questions on topics confronting our world today.
For years, the field of mental health has sought meaningful advances in the treatment of depression, anxiety, PTSD, and addiction. But now, scientists have new hope in the least likely of places: psychedelic drugs.
After decades of stigma, impressive research is showing the power of psychedelic substances like LSD, Ketamine, and psilocybin (magic mushrooms) for their therapeutic benefits.
So what will this newfound Psychedelic Renaissance mean for academia, medicine, and even mankind? Take a trip down this week’s Wonder Newsroom to find out what we uncovered:
PSYCHEDELIC-ASSISTED THERAPIES, BY THE NUMBERS:
31% of adults in the US report symptoms of anxiety and/or depression.
65% of participants across 24 psychedelic studies reported a reduction in anxiety with the use of treatments.
59% of people who previously used psychedelics said they would accept it as a treatment for depression or PTSD.
$11B predicted market size in the psychedelic-assisted drug therapies marketing in the US by 2027.
Check out the 5th edition of the Wonder Newsroom below where we ask & answer the most pressing questions about Psychedelic Drugs:
How has psilocybin been used to treat alcohol addiction?
How are the use of psychedelics monitored in the US?
What is the “Stoned Ape” hypothesis as it relates to human evolution?
Which cultures have been exploring the benefits of psychedelics the longest?
What are the benefits of microdosing psychedelics?
Why was medical research on psychedelics banned until recently?
What are the effects of long-term psychedelic use on the human body?
What is the relationship between professional sports and the use of psychedelics?
